Characterization of Tumor Vasculature in Mouse Brain by USPIO Contrast-Enhanced MRI

Methods in Molecular Biology

Volumn 771, Issue , 2011, Pages 477-487

  Gambarota, Giulio ^a   Leenders, William ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

contrast agent; Gd DTPA; magnetic resonance imaging; mouse brain; T 2 relaxation time; tumor; USPIO; vascular volume; VEGF

Indexed keywords

CONTRAST MEDIUM; DEXTRAN; DIAGNOSTIC AGENT; FERUMOXTRAN-10; GADOLINIUM PENTETATE; MAGNETITE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; ARTICLE; BRAIN; BRAIN TUMOR; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; DEXTRANS; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE;

EID: 80054775325     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-219-9_25     Document Type: Chapter

References (17)

1. Folkman, J. (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3, 65–71.
2. Kusters, B., Leenders, W. P., Wesseling, P., Smits, D., Verrijp, K., Ruiter, D. J., Peters, J. P., van Der Kogel, A. J., and de Waal, R. M. (2002) Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Cancer Res 62, 341–345.
3. Leenders, W. P., Kusters, B., Verrijp, K., Maass, C., Wesseling, P., Heerschap, A., Ruiter, D., Ryan, A., and de Waal, R. M. (2004) Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res 10, 6222–6230.
4. Leenders, W. P., Kusters, B., Pikkemaat, J., Wesseling, P., Ruiter, D., Heerschap, A., Barentsz, J., and de Waal, R. M. (2003) Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI. Int J Cancer 105, 437–443.
5. Claes, A., Gambarota, G., Hamans, B., van Tellingen, O., Wesseling, P., Maass, C., Heerschap, A., and Leenders, W. P. (2008) Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Int J Cancer 122, 1981–1986.
6. Dennie, J., Mandeville, J. B., Boxerman, J. L., Packard, S. D., Rosen, B. R., and Weisskoff, R. M. (1998) NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40, 793–799.
7. Le Duc, G., Peoc’h, M., Remy, C., Charpy, O., Muller, R. N., Le Bas, J. F., and Decorps, M. (1999) Use of T2-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain. Magn Reson Med 42, 754–761.
8. Tropres, I., Grimault, S., Vaeth, A., Grillon, E., Julien, C., Payen, J. F., Lamalle, L., and Decorps, M. (2001) Vessel size imaging. Magn Reson Med 45, 397–408.
9. Bremer, C., Mustafa, M., Bogdanov, A., Ntziachristos, V., Petrovsky, A., and Weissleder, R. (2003) Steady-state blood volume measurements in experimental tumors with different angiogenic burdens—a study in mice Radiology 226, 214–206.
10. Gambarota, G., van Laarhoven, H. W., Philippens, M., Lok, J., van der Kogel, A., Punt, C. J., and Heerschap, A. (2006) Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI. Magn Reson Imaging 24, 279–286.
11. Weisskoff, R. M., Zuo, C. S., Boxerman, J. L., and Rosen, B. R. (1994) Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 31, 601–610.
12. Kennan, R. P., Zhong, J., and Gore, J. C. (1994) Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med 31, 9–21.
13. Kusters, B., Westphal, J. R., Smits, D., Ruiter, D. J., Wesseling, P., Keilholz, U., and de Waal R. M. (2001) The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression. Int J Cancer 92, 176–180.
14. Gambarota, G., Leenders, W. P., Maass, C., Wesseling, P., van der Kogel, A. J., van Tellingen, O., and Heerschap, A. (2008) Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI. Br J Cancer 98, 1784–1789.
15. Enochs, W. S., Harsh, G., Hochberg, F., and Weissleder, R. (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9, 228–232.
16. Taschner, C. A., Wetzel, S. G., Tolnay, M., Froehlich, J., Merlo, A., and Radue, E. W. (2005) Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR Am J Roentgenol 185, 1477–1486.
17. Varallyay, P., Nesbit, G., Muldoon, L. L., Nixon, R. R., Delashaw, J., Cohen, J. I., Petrillo, A., Rink, D., and Neuwelt, E. A. (2002) Comparison of two superparamagnetic viral-sized iron oxide particles ferumox-ides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 23, 510–519.